Australia Pharmaceuticals

Acrux Ltd (ACR)

Track

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Don Brumley Director
Transaction date
Purchase
Price
314.75
Quantity 74,299
Value A$3,192,819
Don Brumley Director
Transaction date
Purchase
Price
484.21
Quantity 97,481
Value A$3,313,844
Don Brumley Director
Transaction date
Purchase
Price
242.08
Quantity 74,176
Value A$2,148,680
Michael Kotsanis Director
Transaction date
Purchase
Price
0.00
Quantity 2,999,792
Value A$420
Geoffrey Brooke Director
Transaction date
Purchase
Price
0.16
Quantity 318,471
Value A$50,000
Norman Gray Director
Transaction date
Purchase
Price
0.16
Quantity 127,389
Value A$20,000
Geoffrey Brooke Director
Transaction date
Purchase
Price
0.16
Quantity 318,471
Value A$50,000
Timothy Oldham Director
Transaction date
Planned purchase
Price
0.09
Quantity 127,389
Value A$10,999
Michael Kotsanis Director
Transaction date
Planned purchase
Price
0.16
Quantity 511,083
Value A$80,240
Ross Dobinson Director
Transaction date
Planned purchase
Price
0.16
Quantity 831,083
Value A$130,480
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-09 2023-03-09 B Purchase Don Brumley Director
74,299
314.75
A$3,192,819 		74,299 314.75 A$3,192,819
2021-11-29 2021-11-29 B Purchase Don Brumley Director
97,481
484.21
A$3,313,844 		97,481 484.21 A$3,313,844
2021-11-26 2021-11-26 B Purchase Don Brumley Director
74,176
242.08
A$2,148,680 		74,176 242.08 A$2,148,680
2021-11-26 2021-11-26 B Purchase Michael Kotsanis Director
2,999,792
0.00
A$420 		2,999,792 0.00 A$420
2021-02-05 2021-02-04 B Purchase Geoffrey Brooke Director
318,471
0.16
A$50,000 		318,471 0.16 A$50,000
2021-02-04 2021-02-04 B Purchase Norman Gray Director
127,389
0.16
A$20,000 		127,389 0.16 A$20,000
2021-02-04 2021-02-04 B Purchase Geoffrey Brooke Director
318,471
0.16
A$50,000 		318,471 0.16 A$50,000
2021-02-04 2021-02-04 PP Planned purchase Timothy Oldham Director
127,389
0.09
A$10,999 		127,389 0.09 A$10,999
2021-02-04 2021-02-04 PP Planned purchase Michael Kotsanis Director
511,083
0.16
A$80,240 		511,083 0.16 A$80,240
2021-02-04 2021-02-04 PP Planned purchase Ross Dobinson Director
831,083
0.16
A$130,480 		831,083 0.16 A$130,480
Explore more

More insider trading research around Acrux Ltd

More insider trades in Australia
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific